Furthermore, inhibition of VLA-4 activity led to suppressed PD-L1 expression, resulting in the conversion of PD-1/PD-L1-induced drug-resistant tumor cells to drug-sensitive tumor cells and decreased PD-1/PD-L1-induced cell proliferation. The gene discussed is CD274; the disease is neoplasm.